Fig. 3.
Fig. 3. Kaplan-Meier actuarial probability of chronic GVHD in patients with CML in first chronic phase treated with nonmyeloablative stem cell transplantation (NST).

Kaplan-Meier actuarial probability of chronic GVHD in patients with CML in first chronic phase treated with nonmyeloablative stem cell transplantation (NST).

or Create an Account

Close Modal
Close Modal